KR20110019382A - 케토티펜 경피 약물 전달 시스템 및 안과 질환의 치료 방법 - Google Patents

케토티펜 경피 약물 전달 시스템 및 안과 질환의 치료 방법 Download PDF

Info

Publication number
KR20110019382A
KR20110019382A KR1020107029270A KR20107029270A KR20110019382A KR 20110019382 A KR20110019382 A KR 20110019382A KR 1020107029270 A KR1020107029270 A KR 1020107029270A KR 20107029270 A KR20107029270 A KR 20107029270A KR 20110019382 A KR20110019382 A KR 20110019382A
Authority
KR
South Korea
Prior art keywords
sensitive adhesive
drug delivery
delivery system
transdermal drug
free base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020107029270A
Other languages
English (en)
Korean (ko)
Inventor
마사히로 야마지
아드차라 퐁페라파트
Original Assignee
센주 유에스에이, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 센주 유에스에이, 인코포레이티드 filed Critical 센주 유에스에이, 인코포레이티드
Publication of KR20110019382A publication Critical patent/KR20110019382A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00544—Plasters form or structure
    • A61F2013/00646—Medication patches, e.g. transcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00655—Plasters adhesive
    • A61F2013/00659—Plasters adhesive polymeric base
    • A61F2013/00663—Plasters adhesive polymeric base acrylic

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020107029270A 2008-05-30 2008-10-08 케토티펜 경피 약물 전달 시스템 및 안과 질환의 치료 방법 Ceased KR20110019382A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5774808P 2008-05-30 2008-05-30
US61/057,748 2008-05-30
US12/236,392 US20090297590A1 (en) 2008-05-30 2008-09-23 Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease
US12/236,392 2008-09-23
PCT/US2008/079211 WO2009145801A1 (en) 2008-05-30 2008-10-08 Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease

Publications (1)

Publication Number Publication Date
KR20110019382A true KR20110019382A (ko) 2011-02-25

Family

ID=41377403

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107029270A Ceased KR20110019382A (ko) 2008-05-30 2008-10-08 케토티펜 경피 약물 전달 시스템 및 안과 질환의 치료 방법

Country Status (9)

Country Link
US (1) US20090297590A1 (enExample)
EP (1) EP2296748B1 (enExample)
JP (1) JP2011523650A (enExample)
KR (1) KR20110019382A (enExample)
CN (1) CN102083494B (enExample)
AR (1) AR070031A1 (enExample)
ES (1) ES2458627T3 (enExample)
TW (1) TW200948401A (enExample)
WO (1) WO2009145801A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5241714B2 (ja) 2006-07-07 2013-07-17 プロテウス デジタル ヘルス， インコーポレイテッド スマートな非経口送達システム
JP5243548B2 (ja) 2007-10-25 2013-07-24 プロテウス デジタル ヘルス， インコーポレイテッド 情報システムのための流体伝達ポート
WO2009067463A1 (en) 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
KR101798128B1 (ko) 2010-02-01 2017-11-16 프로테우스 디지털 헬스, 인코포레이티드 데이터 수집 시스템
SG182824A1 (en) 2010-02-01 2012-09-27 Proteus Biomedical Inc Two-wrist data gathering system
US20130060209A1 (en) * 2011-05-12 2013-03-07 Parker Campbell Tyler Athletic Tape
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
WO2014028396A2 (en) * 2012-08-13 2014-02-20 Hicken Matthew Therapeutic elastic tape
MX2015008021A (es) 2012-12-21 2016-03-04 Teikoku Pharma Usa Inc Composiciones y metodos para administracion transdermica de hormonas y otros agentes medicos.
CN107205929B (zh) * 2015-02-02 2022-06-24 参天制药股份有限公司 多泡沫体及其眼睑施用
USD890936S1 (en) 2018-05-25 2020-07-21 Blacktop Plus, Llc Therapeutic elastic sports tape

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2512805B2 (ja) * 1989-07-14 1996-07-03 積水化学工業株式会社 ケトチフェン経皮吸収製剤
JP2879362B2 (ja) * 1990-08-07 1999-04-05 富山化学工業株式会社 ケトチフェンのプラスター剤
JP4205778B2 (ja) * 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
JP4213432B2 (ja) * 2002-08-28 2009-01-21 久光製薬株式会社 貼付剤
KR20120035220A (ko) * 2003-01-22 2012-04-13 센주 세이야꾸 가부시키가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법
JPWO2005115355A1 (ja) * 2004-05-28 2008-03-27 久光製薬株式会社 貼付製剤
WO2006036899A2 (en) * 2004-09-27 2006-04-06 Corium International, Inc. Transdermal systems for the delivery of estrogens and progestins
JP5075334B2 (ja) * 2004-11-22 2012-11-21 久光製薬株式会社 薬物含有貼付剤
JP4924837B2 (ja) * 2005-04-20 2012-04-25 千寿製薬株式会社 経皮吸収製剤
US20060257460A1 (en) * 2005-05-13 2006-11-16 Jansen Rolf R Multilayer drug delivery system with barrier against antagonist exposure
KR100835074B1 (ko) * 2006-09-27 2008-06-03 조선대학교산학협력단 멜록시캄 경피 흡수제 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
CN102083494B (zh) 2013-11-13
EP2296748A1 (en) 2011-03-23
JP2011523650A (ja) 2011-08-18
EP2296748B1 (en) 2014-04-02
EP2296748A4 (en) 2011-09-28
US20090297590A1 (en) 2009-12-03
ES2458627T3 (es) 2014-05-06
WO2009145801A1 (en) 2009-12-03
CN102083494A (zh) 2011-06-01
AR070031A1 (es) 2010-03-10
TW200948401A (en) 2009-12-01

Similar Documents

Publication Publication Date Title
KR20110019382A (ko) 케토티펜 경피 약물 전달 시스템 및 안과 질환의 치료 방법
JP4629578B2 (ja) 眼疾患治療用経皮吸収型製剤
US20090291127A1 (en) Transdermal anti-dementia active agent formulations and methods for using the same
CN103476404B (zh) 包含活性剂层和活性剂转化层的透皮组合物
RU2764764C2 (ru) Трансдермальные системы доставки мемантина
US20040028726A1 (en) Transdermal systems for the delivery of clonidine
US20100080842A1 (en) Transdermal extended-delivery donepezil compositions and methods for using the same
CZ2003890A3 (cs) Přípravek pro transdermální transport fentanylu
US20100178307A1 (en) Transdermal anti-dementia active agent formulations and methods for using the same
TW201603835A (zh) 里曼提明（ｒｉｖａｓｔｉｇｍｉｎｅ）經皮組成物及使用其之方法
JPH0667835B2 (ja) 医薬組成物
TW202317112A (zh) 經電暈放電處理的經皮傳遞系統
US20120197221A1 (en) Transepidermal drug delivery system containing rivastigmine
TW202317113A (zh) 使用經皮傳遞系統的組合療法處理
JP2007520480A (ja) 少なくとも一つの脂肪酸を含むジヒドロピリジンタイプのカルシウムアンタゴニスト用の経皮的デリバリー器具
WO2018199018A1 (ja) 経皮吸収型製剤およびその製造方法
HK1187817B (en) Transdermal compositions comprising an active agent layer and an active agent conversion layer
HK1161101A (en) Transdermal extended-delivery donepezil compositions and methods for using the same
HK1187817A (en) Transdermal compositions comprising an active agent layer and an active agent conversion layer
HK1207558B (zh) 丙炔基氨基茚满透皮组合物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20101227

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130926

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140924

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20141128

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20140924

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I